Tirzepatide 50mg (10 Vials / Kit)

What is Tirzepatide?

Tirzepatide is a 39-amino-acid synthetic peptide based on the native GIP sequence and engineered to also activate the GLP-1 receptor. A C20 fatty-diacid moiety enables albumin binding, giving it a half-life of approximately five days.

Mechanism of Action

By engaging both incretin receptors, tirzepatide enhances glucose-dependent insulin secretion, lowers glucagon and slows gastric emptying. GIP-receptor activity is thought to contribute additional effects on lipid handling and adipose-tissue metabolism beyond GLP-1 agonism alone.

Research Applications

Tirzepatide is investigated in research on type 2 diabetes, obesity, metabolic dysfunction–associated liver disease and cardiometabolic risk, and is frequently used as a comparator to selective GLP-1 agonists in dual-agonist studies.

Storage & Handling

Supplied as a lyophilized (freeze-dried) powder for maximum stability. Store unopened vials at -20°C, protected from light. Once reconstituted with bacteriostatic water, keep refrigerated at 2–8°C and use within the timeframe appropriate to your study protocol.

Research Use Only

This product is intended as a research chemical only. This designation allows the use of research chemicals strictly for in vitro testing and laboratory experimentation only. All product information available on this website is for educational purposes only. Bodily introduction of any kind into humans or animals is strictly forbidden by law. This product should only be handled by licensed, qualified professionals. This product is not a drug, food, or cosmetic and may not be misbranded, misused or mislabeled as a drug, food or cosmetic.